TAVI-in-homograft (TiH): open transcatheter aortic valve replacement in calcified aortic homograft case reports by M. Gennari et al.
CASE REPORT Open Access
TAVI-in-homograft (TiH): open transcatheter
aortic valve replacement in calcified aortic
homograft case reports
Marco Gennari1* , Ilaria Giambuzzi1, Gianluca Polvani1,2 and Marco Agrifoglio1,2
Abstract
Background: Redo surgery in patient who underwent aortic valve replacement with an aortic homograft can result
technically challenging because of the massive calcification of the conduit.
Case presentation: We present a case of a patient who underwent open surgery on cardiopulmonary bypass
assistance to implant a standard transcatheter aortic bioprosthesis through aortotomy in an off-label procedure and
we discuss its safety and feasibility.
Conclusions: The combination of open cardiac surgery and open trans-aortic implant of a transcatheter prosthesis
may reduce the surgical risk shrinking the technical difficulties that the implantation of a standard surgical prosthesis
would have given.
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Introduction
Surgical aortic valve replacement (SAVR) with a stent-
less root such as homografts may offer some clinical ad-
vantages, like improved hemodynamics performances
and enhanced positive remodeling of the left ventricle
[1], no need for lifelong anticoagulant therapy and rela-
tive low risk of endocarditis. However, these conduits
are subjected to major deterioration, up to 94% at 10
years [2]. The risk of re-operation can be very high [3]
because of massive calcification of the prosthesis and
root that increases the complexity of the surgery, some-
times making replacement also of the conduit necessary.
Open off-label transcatheter aortic valve replacement
(TAVR) can be considered an interesting alternative to
surgical replacement [4].
Hereby we present a case of a male patient who underwent
what we named TAVI-in-Homograft (TiH) procedure.
Case report
A 75-years-old Caucasian male was admitted to our
clinic with a mixed aortic valve pathology. He had a
positive cardiovascular anamnesis, since he underwent
aortic valve replacement with a 27mm size aortic homo-
graft twenty-two years earlier.
Since then he, performed yearly echocardiographic
follow-ups. The first signs of homograft degeneration
presented 12 years after the implant with moderate aor-
tic regurgitation and fibro-sclerosis of the aortic wall.
Ten years later there was evidence of worsening of
aortic regurgitation in association with moderate sten-
osis (trans-valvular mean gradient 36 mmHg and max-
imum velocity of 3,3 m/s).
After 8 months from the last instrumental evaluation
the patient went to the emergency department because
of new onset dyspnea and fever. A new trans-thoracic
echocardiogram showed worsening of the left ventricular
ejection fraction (EF 42%), new evidence of left ventricle
dilation with an end-diastolic volume (EDV) of 245ml
and vegetation on the aortic leaflets. Blood cultures were
positive for C. hominis, which lead to the diagnosis of
endocarditis and specific antibiotic therapy was started
with Meropenem and Ceftriaxone. After three weeks of
therapy, the inflammatory markers were negative, the
clinical aspects of the patient were ameliorated and the
echocardiogram showed improvement of the EF (52%)
and positive remodeling of the left ventricle (EDV 161
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ml) while vegetations and severe aortic regurgitation
were confirmed, and echocardiographic aortic stenosis
parameters worsened (trans-valvular mean gradient 58
mmHg and maximum velocity 5 m/s). Echocardio-
graphic and CT scan images did not show any image
suggestive of abscess.
Because of the frailty of the patient, the complexity of
a redo-surgery in the setting of an extremely calcified
and dilated homograft the heart team proposed an im-
plantation of a transcatheter aortic valve on cardiopul-
monary bypass (CPB) through median sternotomy.
Femoro-femoral CPB was established and median re-
sternotomy performed. The technique was as follow:
– A small aortotomy was performed 2 cm above the
calcified and dilated homograft and then the leaflets
were explored. The leaflets appeared retracted and
heavily calcified (Fig. 1), and permitted only the
passage of an Hegar sized 19 mm. Small pieces of
the homograft were collected to be cultured
– the degenerated leaflets were removed, after careful
evaluation and confirmation of absence of abscesses,
and the height of the coronary ostia measured
(Fig. 2a); the height of the main left was 9 mm while
that of the right coronary ostium was 10 mm and
these measurements were compared with the height
of the transcatheter prosthesis (Fig. 2b). Then the
deployment at nominal volume of a #23 Sapien 3
(Edwards Lifesciences, Irvine, USA) balloon-
expandable prosthesis was performed under direct
view (Fig. 2c)
– at the end we noticed a satisfactory expansion of the
prosthesis-in-homograft (Fig. 3) so we did not per-
form any post-dilatation
– finally thromboendoarterectomy of the degenerated
homograft was performed to remove the most
calcified parts and to allow direct closure with
Proline 4–0. The weaning from CPB was quick and
easy.
The following in-hospital course was uneventful, the
homograft biopsies were negative and the post-operative
echocardiogram showed only a mild residual aortic re-
gurgitation (partially para-valvular). The patient was dis-
charged in the 7th post-operative day.
After 14 months from the procedure the patient is
alive and well, asymptomatic, and the residual mild aor-
tic regurgitation is stable.
Discussion
Valvular and vascular tissues from a cadaveric donor are
often utilized in congenital malformation and in the
Fig. 1 Intraoperative picture of the degenerated homograft. Notice
the calcified leaflet and their fixed opening position
Fig. 2 We measured the virtual basal ring to coronary ostia height
(a) and we compared them with the prosthesis height (b). Finally,
we deployed the valve at the most convenient point (c)
Fig. 3 Intraoperative picture of the final result. Once deployed we
explored the prosthesis boundary and we judged the sealing
satisfactory. No post-dilatation was needed in this case
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adult in the setting of acute endocarditis due to their
more likely resistance to the infections.
We previously report other cases of severe calcified
degenerated homograft that needed other than surgical
replacement due to the impossibility to perform secure
decalcification [5]. The trans-aortic route, introduced in
2012 by Bapat [6], has been proved to be safe when pa-
tients are correctly selected [7, 8].
Trans-aortic TAVR was chosen after exclusions of the
sutureless valves. First of all, we could not use the
Intuity prosthesis because of the impossibility to place
any stitches on the homograft. The other possible choice
was the Perceval prosthesis, but we avoided it because of
the higher profile of the prosthesis (its stented structure
would have reached over the homograft, which was any-
way dilated, and the support on the ascending aorta
would have been less table) and because of the higher
and larger aortotomy that it would have needed. More-
over, any peripheral approach was excluded to avoid the
need of a wire, that could have easily teared up the spot-
ted calcifications expanding from the homograft to the
ascending aorta. Instead, a trans-apical approach has
been excluded because of the low EF.
In such cases a TAVI-in-Homograft (TiH) procedure
may be the only reasonable possibility to overcome the
anatomical finding discovered at the operating theatre,
as also other groups [9, 10] have described.
In this case we have presented the heart team evalu-
ated the frailty of the patient and the anatomy of the
homograft. The graft was so calcified that a standard
surgery requiring stitches would have been technically
impossible, but it would have also made very dangerous
a standard transcatheter procedure because of the aortic
calcification [11, 12] and the poor control upon releasing
the balloon-expandable prosthesis.
Conclusion
The combination of open cardiac surgery with CPB and
open trans-aortic implant of a transcatheter prosthesis
decreased the surgical risk and permitted to perform the
procedure safely, shrinking the technical difficulties that
the implantation of a standard surgical prosthesis would
have given.
Larger series and studies on this particular subpopula-
tion of patients are warranted to drive final conclusion.
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